|Articles|September 16, 2019
Signant Health Brings eConsent Solution to China
Advertisement
Signant Health has been selected to provide electronic informed consent for a significant neuroscience study by the Shanghai Mental Health Center. This investigator-led Schizophrenia trial will enroll hundreds of patienta and implement Signant’s TrialConsent solution in China.
To learn more, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
A Shot in the Arm to Traditional Vaccine Trial Strategy
5